Not applicableStudy completedNCT00267826What this trial is testingImmunopharmacological Effects of Rituximab in Atopic DermatitisWho this might be right forDermatitis, Atopic University of Bern 6
Early research (Phase 1)Study completedNCT07466940What this trial is testingA Clinical Study to Evaluate SM17 in Healthy ParticipantsWho this might be right forAtopic DermatitisAsthmaInflammatory Bowel Disease SinoMab BioScience Ltd 30
Large-scale testing (Phase 3)Study completedNCT00991146What this trial is testingEfficacy and Safety Study of Canakinumab Administered for 6 Months (24 Weeks) in Japanese Patients With Cryopyrin-associated Periodic Syndromes Followed by an Extension PhaseWho this might be right forCryopyrin-associated Periodic SyndromesFamilial Cold Autoinflammatory SyndromeMuckle-Wells Syndrome+1 more Novartis Pharmaceuticals 19
Early research (Phase 1)Study completedNCT00000886What this trial is testingA Phase I Safety and Immunogenicity Trial of HIV-1 gp120 C4-V3 Hybrid Polyvalent Peptide Immunogen Mixed in Mineral Oil Containing Mannose Mono-Oleate (IFA)Who this might be right forHIV Infections National Institute of Allergy and Infectious Diseases (NIAID) 24
Early research (Phase 1)Looking for participantsNCT07181369What this trial is testingGTX-B001 in Healthy Subjects and Patients With Chronic Inducible UrticariaWho this might be right forHealthy SubjectsCold UrticariaSymptomatic Dermographism+1 more Granular Therapeutics Limited 72
Not applicableStudy completedNCT00001759What this trial is testingAssessment of Lung Inflammation in Patients With Atopic Asthma Using Positron Emission TomographyWho this might be right forAsthmaHypersensitivityLung Diseases+1 more National Institute of Allergy and Infectious Diseases (NIAID) 95
Not applicableLooking for participantsNCT02593565What this trial is testingVasculitis Pregnancy RegistryWho this might be right forVasculitisBehcet's DiseaseCNS Vasculitis+12 more University of Pennsylvania 100
Testing effectiveness (Phase 2)Active Not RecruitingNCT06680947What this trial is testingA Phase IIb Study of 610 in Participants With Severe Eosinophilic AsthmaWho this might be right forAsthma Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. 225
Large-scale testing (Phase 3)UnknownNCT04018131What this trial is testingThe Efficacy of Cimetidin for Acute - Extrinsic Atopic Dermatitis Treated With Standard TherapyWho this might be right forAtopic DermatitisImmunoglobulin E Concentration, Serum Fakultas Kedokteran Universitas Indonesia 26
Large-scale testing (Phase 3)Study completedNCT04709575What this trial is testingStudy to Assess the Efficacy of Anti-Bet v 1 Monoclonal Antibodies in Adults to Reduce Symptoms of Seasonal Allergic RhinitisWho this might be right forAllergic RhinitisConjunctivitis Regeneron Pharmaceuticals 353
Early research (Phase 1)Study completedNCT06494345What this trial is testingGenolair in Two Dosage Forms (Solution and Lyophilisate) and Xolair® in Healthy VolunteersWho this might be right forAllergic Asthma AO GENERIUM 180
Testing effectiveness (Phase 2)UnknownNCT05466877What this trial is testingMG-K10 in Subjects With Atopic DermatitisWho this might be right forAtopic Dermatitis Shanghai Mabgeek Biotech.Co.Ltd 163
Post-approval studies (Phase 4)Study completedNCT03183024What this trial is testingTreatment of Chronic Urticarial Unresponsive to H1-antihistamines With an Anti-IL5Ralpha Monoclonal AntibodyWho this might be right forChronic Idiopathic Urticaria Jonathan A. Bernstein, MD 12
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07110662What this trial is testingNew Therapeutic Target for Toxic Epidermal Necrolysis (TEN) Using Anti-CD38+ Monoclonal Antibodies.Who this might be right forToxic Epidermal NecrolysisImmunotherapyCutaneous Adverse Drug Reactions (CADR) Hospices Civils de Lyon 9
Testing effectiveness (Phase 2)UnknownNCT05382910What this trial is testingMG-K10 in Subjects With AsthmaWho this might be right forAsthma Shanghai Mabgeek Biotech.Co.Ltd 180
Testing effectiveness (Phase 2)Study completedNCT05186909What this trial is testingCM310 in Subjects With Moderate to Severe AsthmaWho this might be right forAsthma Keymed Biosciences Co.Ltd 52
Testing effectiveness (Phase 2)Study completedNCT06015308What this trial is testingInvestigate Vaccine Responses in Subcutaneous Amlitelimab Treated Atopic Dermatitis Participants Aged 18 Years and Older Compared With PlaceboWho this might be right forDermatitis Atopic Sanofi 224
Testing effectiveness (Phase 2)Study completedNCT00584584What this trial is testingAn Exploratory Study of the Effects of a Single Dose of QAX576 (an Interleukin-13 Monoclonal Antibody) on Simulated HayfeverWho this might be right forAllergic Rhinitis Novartis 36
Post-approval studies (Phase 4)Study completedNCT00670930What this trial is testingEfficacy of Omalizumab in Adults (18-60 Years of Age) With Moderate-Severe, Persistent Allergic Asthma, Despite Receiving Inhaled Corticosteroids and Long Acting Beta-agonistsWho this might be right forAllergic Asthma Novartis Pharmaceuticals 36
Post-approval studies (Phase 4)Study completedNCT01430403What this trial is testingPreventative Omalizumab or Step-up Therapy for Severe Fall ExacerbationsWho this might be right forAsthma National Institute of Allergy and Infectious Diseases (NIAID) 478